What we offer
We offer expertise across all major asset classes, with investment teams situated around the world
We offer a wide range of equity strategies encompassing different geographic focuses and investment styles. The teams include those with a global perspective, those with a regional focus – Europe, US, Asia Pacific and Emerging Markets – and those invested in specialist sectors. A range of growth, value and absolute return styles are employed. These teams generally apply processes based on fundamental research and bottom-up stock picking.
US$171.3bn in assets under management*
Insights from our equity team to help clients navigate the risk and opportunities
Our Fixed Income teams provide coverage across the asset class, applying a wide range of differentiated techniques. These teams include those adopting global unconstrained approaches through to those with more focused mandates. The capabilities of these teams can be accessed through individual strategies and are combined where appropriate to form multi-strategy offerings.
US$59.8bn in assets under management*
Fixed Income Perspectives
Quarterly insight from our fixed income teams to help clients navigate the risks and opportunities ahead.
The Janus Henderson Alternatives grouping includes teams with different areas of focus and approach. The Diversified Alternatives Team brings together a cross-asset class combination of alpha generation, risk management, and efficient beta replication strategies. These include multi-strategy, liquid alternatives, agriculture, and global commodities/managed futures.
US$10.7bn in assets under management*
Janus Henderson Multi-Asset includes teams in the US and UK. In the US, our teams manage US and global asset allocation strategies. In the UK, we have asset allocation specialists, traditional multi-manager investors, and those focused on alternative asset classes.
US$45.5bn in assets under management*
Watch the investment team recap for Q1 2022.
Video filmed as of April 2022.
*As at 31 December 2022
Banking sector update: Taking steps in the right direction
Regulatory actions have helped to calm the banking sector. Going forward, the bifurcation between winners and losers could widen.Read more
Global Perspectives: Why biotech could be embarking on a new decade of growth
A wave of innovative therapies is beginning to hit the market, transforming the prospects of the biotech firms behind the science.Read more
Quick view: How will SVB’s demise impact technology stocks?
Implications of the collapse of Silicon Valley Bank for the technology sector.Read more